Skip to main content

Proinflammatory GSDMD activation in live macrophages and DLBCL cells marks cognate interactions and better prognosis.

Publication ,  Journal Article
Kong, X; Xu-Monette, ZY; Xu, Z; Hsi, E; Zhao, X; Yan, H; Nunns, H; Au, K; Visco, C; Tzankov, A; Dybkaer, K; Yao, S; Wu, D; Wang, C; Xu, AM ...
Published in: Blood Adv
December 4, 2025

Pyroptosis is a form of programmed cell death characterized by the cleavage of gasdermin (GSDM) family proteins that form pores in the plasma membrane, cell rupture, and the release of pro-inflammatory cytokines. In this study, we performed immunohistochemistry for cleaved GSDMD, GSDME-N-terminal, and GSDMC in two different cohorts of diffuse large B-cell lymphoma (DLBCL), and analyzed their prognostic and immune impact. The results showed frequent cleaved GSDMD (GSDMD-N-terminal) expression. Only cytoplasmic GSDMD-N-terminal expression correlated with significantly better patient survival in two cohorts. In contrast, GSDME was mainly expressed in the vascular endothelium, correlated with significantly adverse prognostic effect. Correlating with the multiplex fluorescent immunohistochemistry (mfIHC) results, we found that cytoplasmic GSDMD-N-terminal expression was associated with increased CD38+ (activated) M1 macrophages in both cohorts, cognate interactions between live DLBCL cells and activated M1 macrophages (and T cells), and lower PD-1/PD-L1 expression in the analyzed cases. In contrast, T cell pyroptosis, lymphoma cell resistance to cell death, and phagocytosis by M2 macrophages were observed in cells with nuclear GSDMD-N-terminal expression. Bulk gene expression profiling and deconvolution analysis for patients with cytoplasmic GSDMD-N-terminal expression revealed downregulation of "Don't eat me" signaling genes, upregulation of many RNA genes, decreased frequency of "Inflammatory" lymphoma microenvironment subtype, increased abundance of prognostically favorable cell states and ecotypes, and decreased abundance of T cell exhaustion state. In summary, this study showed distinct cellular and subcellular patterns of three gasdermin proteins and their associated immune response phenotypes and prognostic effects, with implications for novel therapeutic strategies for B-cell lymphoma.

Duke Scholars

Published In

Blood Adv

DOI

EISSN

2473-9537

Publication Date

December 4, 2025

Location

United States

Related Subject Headings

  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kong, X., Xu-Monette, Z. Y., Xu, Z., Hsi, E., Zhao, X., Yan, H., … Young, K. H. (2025). Proinflammatory GSDMD activation in live macrophages and DLBCL cells marks cognate interactions and better prognosis. Blood Adv. https://doi.org/10.1182/bloodadvances.2025017643
Kong, Xue, Zijun Y. Xu-Monette, Zhenming Xu, Eric Hsi, Xiaoxian Zhao, Hui Yan, Harry Nunns, et al. “Proinflammatory GSDMD activation in live macrophages and DLBCL cells marks cognate interactions and better prognosis.Blood Adv, December 4, 2025. https://doi.org/10.1182/bloodadvances.2025017643.
Kong X, Xu-Monette ZY, Xu Z, Hsi E, Zhao X, Yan H, et al. Proinflammatory GSDMD activation in live macrophages and DLBCL cells marks cognate interactions and better prognosis. Blood Adv. 2025 Dec 4;
Kong, Xue, et al. “Proinflammatory GSDMD activation in live macrophages and DLBCL cells marks cognate interactions and better prognosis.Blood Adv, Dec. 2025. Pubmed, doi:10.1182/bloodadvances.2025017643.
Kong X, Xu-Monette ZY, Xu Z, Hsi E, Zhao X, Yan H, Nunns H, Au K, Visco C, Tzankov A, Dybkaer K, Yao S, Wu D, Wang C, Xu AM, Pan Z, Parsons BM, Chiu A, Tam W, Montes-Moreno S, Zhan F, Bernal-Mizrachi L, Zu Y, Zhang S, Møller MB, Chen W, Au Q, Merchant AA, Bhagat G, Li Y, Young KH. Proinflammatory GSDMD activation in live macrophages and DLBCL cells marks cognate interactions and better prognosis. Blood Adv. 2025 Dec 4;

Published In

Blood Adv

DOI

EISSN

2473-9537

Publication Date

December 4, 2025

Location

United States

Related Subject Headings

  • 3201 Cardiovascular medicine and haematology